adamantane has been researched along with carboplatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bandyopadhyay, D; Dabrowiak, JC; Luk, YY; Prashar, D; Shi, Y | 1 |
| Peng, Q; Su, R; Wang, W; Zhang, X | 1 |
2 other study(ies) available for adamantane and carboplatin
| Article | Year |
|---|---|
Adamantane-platinum conjugate hosted in β-cyclodextrin: enhancing transport and cytotoxicity by noncovalent modification.
Topics: Adamantane; Antineoplastic Agents; beta-Cyclodextrins; Carboplatin; Cell Line, Tumor; Cell Survival; Drug Carriers; Fluorescein-5-isothiocyanate; Humans; Mass Spectrometry; Microscopy, Confocal; Plasmids; Platinum | 2011 |
Self-assembling porphyrin conjugate-carboplatin(IV) prodrug nanoparticles for enhancing high efficacy nasopharyngeal cancer and low systemic toxicity.
Topics: Adamantane; Animals; beta-Cyclodextrins; Carboplatin; Cell Line, Tumor; Mice; Nanoparticles; Nasopharyngeal Neoplasms; Photosensitizing Agents; Porphyrins; Prodrugs; Reactive Oxygen Species | 2022 |